Merck & Co., Inc.
MRK
$81.53
$0.390.48%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.84% | 35.69% | 18.56% | -42.13% | 14.55% |
| Total Depreciation and Amortization | 0.57% | -5.03% | -2.79% | 7.50% | 16.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.67% | -83.26% | -81.38% | 1,779.69% | -83.82% |
| Change in Net Operating Assets | 39.14% | -100.11% | -171.84% | 355.14% | 70.08% |
| Cash from Operations | 31.72% | -27.54% | -62.87% | 64.82% | 82.43% |
| Capital Expenditure | 42.47% | -41.73% | -19.67% | 1.01% | 8.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 99.94% | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 96.23% | 68.51% | -278.45% | 201.80% | -220.35% |
| Cash from Investing | 48.22% | -2.98% | 62.44% | -259.68% | 22.31% |
| Total Debt Issued | -- | -- | 100.00% | -100.03% | -- |
| Total Debt Repaid | 100.00% | -363.82% | -- | -- | 100.00% |
| Issuance of Common Stock | -36.84% | 58.33% | 140.00% | -93.15% | -16.09% |
| Repurchase of Common Stock | -15.55% | -138.04% | -10.14% | -76.89% | -105.74% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.32% | -5.07% | 0.10% | 1.66% | -1.85% |
| Other Financing Activities | -223.33% | -42.86% | -31.25% | 85.45% | -182.05% |
| Cash from Financing | 38.21% | -91.26% | -24.08% | -299.42% | 143.21% |
| Foreign Exchange rate Adjustments | 139.74% | 142.51% | -224.83% | 458.54% | 40.58% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.63% | -234.74% | -141.33% | -41.86% | 560.58% |